CVRdatabase
Menu

10x Genomics Denmark ApS

Private limited companyCVR 40243224København ØActive

10x Genomics Denmark ApS is a private limited company, based in København Ø, active in manufacture of pharmaceutical preparations, founded in 2019. Net profit fell 16% from 2024 to 2025, ending at DKK 155k. Equity grew to DKK 974k in 2025. 8 other companies in the database are registered at the same address.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 3.4m+0.8% vs. 2024
Net profitDKK 155k−15.5% vs. 2024
EquityDKK 974k+18.9% vs. 2024
Employees2latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Net profit fell 16% (2024 → 2025), to DKK 155k.
  • Equity rose 19% (2024 → 2025), to DKK 974k.

Management and owners, last 24 months

  • New in management: James Sears Bryant (director, 16/09/2025).
  • Stepped down: Eric Stewart Whitaker (director, 16/09/2025).

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 10mDKK 0DKK 10mDKK 20mDKK 30mDKK 40m202020212022202320242025
EquityNet profit
Financial figures for 10x Genomics Denmark ApS
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit−1,60252,1917,3342,0593,4163,442+0.8%
Operating profit (EBIT)−2,57147,126894−591269198−26.4%
Profit before tax−2,60950,9293,673−556236199−15.9%
Net profit−2,02739,8042,820−587183155−15.5%
Total assets2,48050,3636,1402,3421,4301,560+9.1%
Equity−1,40238,4021,222635819974+18.9%
Liabilities3,88111,9504,9141,707611587−4.1%
Cash and cash equivalents1,3472,2284,8862,3067541,502+99.3%
Average number of employees2––22––

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 10mDKK 0DKK 10mDKK 20mDKK 30mDKK 40mDKK 50m202020212022202320242025
Gross profitMedian, the industry (59 companies)

Annual reports

6 financial years
Annual reports for 10x Genomics Denmark ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202515/05/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202422/05/2025The companyPDFXBRL
202301/01/2023 – 31/12/202327/06/2024The companyPDFXBRL
202201/01/2022 – 31/12/202223/06/2023The companyPDFXBRL
202101/01/2021 – 31/12/202123/06/2022The companyPDFXBRL
202001/01/2020 – 31/12/202024/06/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0112208/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

59 companies in the database

Comparison with the other companies in manufacture of pharmaceutical preparations based on the latest financial year.

Gross profitDKK 3.4mNo. 26 of 57
Better than 55% of the companies in the industry
EquityDKK 974kNo. 41 of 59
Better than 31% of the companies in the industry
Number of employees2No. 43 of 59
Better than 28% of the companies in the industry

Industry median: gross profit DKK 2.8m, net profit −DKK 2.2m, equity DKK 5.2m, 10 employees.

DKK 266kDKK 8.3mDKK 258mDKK 8bnDKK 79.6bnHere
Distribution of gross profit for 34 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 19,924of 69,742
Better than 71%
No. 34,058of 69,964
Better than 51%
Same industry and fewer than 20 employees37 companies in the comparison
No. 9of 36
Better than 77%
No. 22of 37
Better than 42%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 11,804of 33,588
Better than 65%
No. 15,641of 33,687
Better than 54%
All companies of type ApS66,508 companies in the comparison
No. 19,805of 66,379
Better than 70%
No. 29,922of 66,505
Better than 55%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Manufacture of pharmaceutical preparations
Gross profit
  1. 10x Genomics Denmark ApSDKK 3.4m
  2. Novo Nordisk A/SDKK 250.3bn
  3. H. Lundbeck A/SDKK 20.4bn
Net profit
  1. 10x Genomics Denmark ApSDKK 155k
  2. Novo Nordisk A/SDKK 102.4bn
  3. H. Lundbeck A/SDKK 3.2bn
Equity
  1. 10x Genomics Denmark ApSDKK 974k
  2. Novo Nordisk A/SDKK 194bn
  3. H. Lundbeck A/SDKK 24.9bn
Employees
  1. 10x Genomics Denmark ApS2
  2. Novo Nordisk A/S27,279
  3. H. Lundbeck A/S2,261

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • 10x Genomics, Inc.100%
10x Genomics Denmark ApS

Management

2 active registrations

Executive management

Executive management at 10x Genomics Denmark ApS
NameRoleAppointed
Adam Samuel TaichDirector28/08/2024
James Sears BryantDirector16/09/2025
Founders
Sunil Kumar Saini, Molior Holding ApS, Hadrup BioMed Holding ApS, Sebastian Hartmut Springer, JCBS Holding GmbH
Former management (8)
Former management at 10x Genomics Denmark ApS
NameRoleAppointedResigned
Søren Nyboe JakobsenCEO31/01/201907/01/2021
Søren Nyboe JakobsenBoard member31/01/201908/01/2021
Sunil Kumar SainiBoard member31/01/201908/01/2021
Sebastian Hartmut SpringerChair of the board31/01/201908/01/2021
Søren Fogh AagaardBoard member02/04/201908/01/2021
Justin John McAnearDirector01/01/202128/08/2024
Søren Nyboe JakobsenDirector08/01/202118/11/2022
Eric Stewart WhitakerDirector08/01/202116/09/2025

Signing rule: Selskabet tegnes af én direktør.

Address and production units

1 active production units

Lyngbyvej 20
2100 København Ø

København Municipality · Postcode 2100

Other companies at the address (8)

Production units
Production unitAddressEmployeesP number
10x Genomics Denmark ApSLyngbyvej 20, 2100 København Ø21024388588

Purpose

Selskabets formål er at fremstille og sælge instrumenter og forbrugsmaterialer til kunder, der beskæftiger sig med forsknings- og udviklingsaktiviteter inden for bioteknologi, liv og medicinsk videnskab.

The purpose is quoted from the register in Danish.

Changes year by year

40 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20253 changesmanagement 2 · accounts 1
  • James Sears Bryant appointed director
  • Eric Stewart Whitaker stepped down as director
  • Annual report for 2024 published
20243 changesmanagement 2 · accounts 1
  • Adam Samuel Taich appointed director
  • Justin John McAnear stepped down as director
  • Annual report for 2023 published
20232 changesaddress 1 · accounts 1
  • Moved to Lyngbyvej 20, 2100 København Ø
  • Annual report for 2022 published
20223 changesname 1 · management 1 · accounts 1
  • Name changed from Tetramer Shop ApS to 10x Genomics Denmark ApS
  • Søren Nyboe Jakobsen stepped down as director
  • Annual report for 2021 published
202115 changesaccounts 1 · management 8 · ownership 6
  • Annual report for 2020 published
  • Søren Nyboe Jakobsen appointed director
  • Eric Stewart Whitaker appointed director
  • Søren Fogh Aagaard stepped down as board member
  • Sebastian Hartmut Springer stepped down as chair of the board
  • Sunil Kumar Saini stepped down as board member
  • Søren Nyboe Jakobsen stepped down as board member
  • 10x Genomics, Inc. registered as owner (100%)
  • Sunil Kumar Saini is no longer registered as owner
  • MOLIOR HOLDING ApS is no longer registered as owner
  • Hadrup BioMed Holding ApS is no longer registered as owner
  • Sebastian Hartmut Springer is no longer registered as owner
  • JCBS Holding GmbH is no longer registered as owner
  • Søren Nyboe Jakobsen stepped down as ceo
  • Justin John McAnear appointed director
201913 changescapital 1 · management 5 · address 1 · founded 1 · ownership 5
  • Share capital changed from 50,000 DKK to 51,590 DKK
  • Søren Fogh Aagaard appointed board member
  • Moved to Diplomvej 381, 2800 Kongens Lyngby
  • Registered as Tetramer Shop ApS
  • Søren Nyboe Jakobsen appointed ceo
  • Sebastian Hartmut Springer appointed chair of the board
  • Sunil Kumar Saini appointed board member
  • Søren Nyboe Jakobsen appointed board member
  • Sunil Kumar Saini registered as owner (20%)
  • MOLIOR HOLDING ApS registered as owner (25%)
  • Hadrup BioMed Holding ApS registered as owner (20%)
  • Sebastian Hartmut Springer registered as owner (20%)
  • JCBS Holding GmbH registered as owner (5%)

Related companies

Same industry in København

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction